Cytyc to Buy Adiana

Cytyc Corp. (Nasdaq: CYTC) has agreed to acquire Adiana Inc., a Redwood City, Calif.-based developer of a non-incisional alternative to tubal ligation for permanent female contraception. The total deal could be worth up to $215 million, including an initial $60 million cash payment and possible earn-outs. Adiana has raised around $55 million in total VC funding since its 1997 inception, from firms like Abingworth Management, Alloy Ventures, Boston Scientific, Charter Venture Capital, Delphi Ventures, Forward Ventures, Kaiser Permanente Ventures, Oakwood Medical Investors, OrbiMed Advisors, Stanford University and Tulliss-Dickerson & Co. www.cytec.com www.adiana.com